These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 175653)

  • 21. Treatment with chlorpropamide-phenformin combination in adult, obese, ketosis-resistant diabetics.
    Lev-Ran AS
    Isr J Med Sci; 1971 Jun; 7(6):727-32. PubMed ID: 4997820
    [No Abstract]   [Full Text] [Related]  

  • 22. Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance.
    Flier JS; Kahn CR; Roth J; Bar RS
    Science; 1975 Oct; 190(4209):63-5. PubMed ID: 170678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of chlorpropamide and glibenclamide treatment of maturity-onset diabetes: control assessed by fasting plasma glucose concentrations.
    Ward EA; Lang DA; Phillips MR; Turner RC
    Diabetes Care; 1981; 4(2):293-5. PubMed ID: 6783374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased insulin binding of mononuclear leukocytes in diabetic patients with hyperlipidemia.
    Hiramatsu K; Sakai H; Arimori S
    Tokai J Exp Clin Med; 1980 Apr; 5(2):137-45. PubMed ID: 6998049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The long-term effects of chlorpropamide on insulin, C-peptide, and proinsulin secretion.
    Elkeles RS; Heding LG; Paisey RB
    Diabetes Care; 1982; 5(4):427-9. PubMed ID: 6759080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucagon binding and adenylate cyclase activity in liver membranes from untreated and insulin-treated diabetic rats.
    Soman V; Felig P
    J Clin Invest; 1978 Mar; 61(3):552-60. PubMed ID: 205552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potentiation of hypoglycemic effect of chlorpropamide and phenfromin by halofenate.
    Kudzma DJ; Friedberg SJ
    Diabetes; 1977 Apr; 26(4):291-5. PubMed ID: 321288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
    Tattersall RB
    Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
    [No Abstract]   [Full Text] [Related]  

  • 29. Lysosomal enzyme activities and low density lipoprotein receptors in circulating mononuclear cells. Effect of insulin therapy in diabetic patients.
    Henze K; Chait A
    Diabetologia; 1981 Jun; 20(6):625-9. PubMed ID: 6266905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of insulin receptors in obesity-related diabetes.
    Taylon A; Blackard WG
    Horm Metab Res; 1982 Dec; 14(12):623-6. PubMed ID: 6759356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isoproterenol-stimulated C-peptide and insulin secretion in diabetic and nonobese normal subjects: decreased hepatic extraction of endogenous insulin in diabetes.
    Sando H; Lee YS; Iwamoto Y; Ikeuchi M; Kosaka K
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1143-9. PubMed ID: 6999008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model.
    Koopmans SJ; Mroz Z; Dekker R; Corbijn H; Ackermans M; Sauerwein H
    Metabolism; 2006 Jul; 55(7):960-71. PubMed ID: 16784971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of short- and long-term chlorpropamide therapy on oral glucose tolerance and erythrocyte insulin receptors in non-obese non-insulin dependent diabetes mellitus.
    el-Andere W; Lerario AC; Wajchenberg BL
    Horm Metab Res; 1987 Jun; 19(6):257-63. PubMed ID: 3623414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus.
    Kolterman OG; Gray RS; Griffin J; Burstein P; Insel J; Scarlett JA; Olefsky JM
    J Clin Invest; 1981 Oct; 68(4):957-69. PubMed ID: 7287908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.
    Matthews DR; Cull CA; Stratton IM; Holman RR; Turner RC
    Diabet Med; 1998 Apr; 15(4):297-303. PubMed ID: 9585394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperglycemia-induced intracellular depletion of ascorbic acid in human mononuclear leukocytes.
    Chen MS; Hutchinson ML; Pecoraro RE; Lee WY; Labbé RF
    Diabetes; 1983 Nov; 32(11):1078-81. PubMed ID: 6357907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of a fat free, high carbohydrate diet on diabetic subjects with fasting hyperglycemia.
    Brunzell JD; Lerner RL; Porte D; Bierman EL
    Diabetes; 1974 Feb; 23(2):138-42. PubMed ID: 4811509
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of chronic oral antidiabetic therapy on insulin and glucagon responses to a meal.
    Tsalikian E; Dunphy TW; Bohannon NV; Lorenzi M; Gerich JE; Forsham PH; Kane JP; Karam JH
    Diabetes; 1977 Apr; 26(4):314-21. PubMed ID: 849812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormone receptors, 5. Binding of glucagon and insulin to human circulating mononuclear cells in diabetes mellitus.
    Goldstein S; Blecher M; Binder R; Perrino PV; Recant L
    Endocr Res Commun; 1975; 2(4-5):367-76. PubMed ID: 171138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transient neonatal diabetes mellitus. Treatment with chlorpropamide.
    Kuna P; Addy DP
    Am J Dis Child; 1979 Jan; 133(1):65-6. PubMed ID: 760514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.